Cite
Concurrent targeting of BMI1 and CDK4/6 abrogates tumor growth in vitro and in vivo
MLA
Radhakrishnan Vishnubalaji, et al. “Concurrent Targeting of BMI1 and CDK4/6 Abrogates Tumor Growth in Vitro and in Vivo.” Scientific Reports, vol. 9, no. 1, Sept. 2019, pp. 1–13. EBSCOhost, https://doi.org/10.1038/s41598-019-50140-0.
APA
Radhakrishnan Vishnubalaji, Nehad M. Alajez, Ramesh Elango, Musaad Alfayez, Yasser A. Alshawakir, Abdullah Aldahmash, Sarah Binhamdan, Abdulaziz Siyal, & Muthurangan Manikandan. (2019). Concurrent targeting of BMI1 and CDK4/6 abrogates tumor growth in vitro and in vivo. Scientific Reports, 9(1), 1–13. https://doi.org/10.1038/s41598-019-50140-0
Chicago
Radhakrishnan Vishnubalaji, Nehad M. Alajez, Ramesh Elango, Musaad Alfayez, Yasser A. Alshawakir, Abdullah Aldahmash, Sarah Binhamdan, Abdulaziz Siyal, and Muthurangan Manikandan. 2019. “Concurrent Targeting of BMI1 and CDK4/6 Abrogates Tumor Growth in Vitro and in Vivo.” Scientific Reports 9 (1): 1–13. doi:10.1038/s41598-019-50140-0.